Access the full text.
Sign up today, get DeepDyve free for 14 days.
Elena Sadovnikova, Hans Stauss (1996)
Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy.Proceedings of the National Academy of Sciences of the United States of America, 93 23
Keiko Udaka, Karl-Heinz Wiesmtiller, S. Kienle, Gfinther Jung, Peter Walden (1995)
Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide librariesThe Journal of Experimental Medicine, 181
U. Staerz, F. Zepp, Rita Schmid, M. Hill, J. Rothbard (1989)
Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptideEuropean Journal of Immunology, 19
H. Rammensee, Jutta Bachmann, S. Stevanović (1998)
MHC Ligands and Peptide Motifs
H. Macdonald, J. Cerottini, J. Ryser, J. Maryanski, C. Taswell, M. Widmer, K. Brunner (1980)
Quantitation and Cloning of Cytolytic T Lymphocytes and their PrecursorsImmunological Reviews, 51
Bellone Bellone, Lezzi Lezzi, Manfredi Manfredi, Protti Protti, Dellabona Dellabona, Casorati Casorati, Rugarli Rugarli (1994)
Murine cell surface transferrin receptor: studies with an anti‐receptor monoclonal antibodyEur. J. Immunol., 24
D. Weber, N. Terrell, Y. Zhang, G. Strindberg, J. Martin, A. Rudensky, N. Braunstein (1995)
Requirement for peptide in alloreactive CD4+ T cell recognition of class II MHC molecules.Journal of immunology, 154 10
J. Kaye, C. Janeway (1984)
The Fab fragment of a directly activating monoclonal antibody that precipitates a disulfide-linked heterodimer from a helper T cell clone blocks activation by either allogeneic Ia or antigen and self-IaThe Journal of Experimental Medicine, 159
Dos Reis Dos Reis, Shevach Shevach (1983)
Antigen presenting cells from nonresponder strain 2 guinea pigs are fully competent to present bovine insulin B chain to responder strain 13 T cells. Evidence against a determinant selection model and in favour of a clonal deletion model of immune response gene functionJ. Exp. Med., 157
P. Matzinger, J. Waterfield (1980)
Is self tolerance H–2 restricted?Nature, 285
P. Bowness, Rachel Allen, A. McMichael (1994)
Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27European Journal of Immunology, 24
T. Elliott, H. Eisen (1990)
Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule.Proceedings of the National Academy of Sciences of the United States of America, 87 13
H. Ljunggren, K. Kärre (1985)
Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanismThe Journal of Experimental Medicine, 162
S. Man, R. Salter, V. Engelhard (1992)
Role of endogenous peptide in human alloreactive cytotoxic T cell responses.International immunology, 4 3
Suchsmitta Chattopadhyay, Matthias Theobald, J. Biggs, Linda Sherman (1994)
Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivityThe Journal of Experimental Medicine, 179
S. Malarkannan, F. Gonzalez, V. Nguyen, G. Adair, N. Shastri (1996)
Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes.Journal of immunology, 157 10
S. Malarkannan, T. Serwold, V. Nguyen, L. Sherman, N. Shastri (1996)
The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma.Proceedings of the National Academy of Sciences of the United States of America, 93 24
M. Alexander-Miller, K. Burke, U. Koszinowski, T. Hansen, J. Connolly (1993)
Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.Journal of immunology, 151 1
W. Heath, M. Hurd, F. Carbone, L. Sherman (1989)
Peptide-dependent recognition of H–2Kb by alloreactive cytotoxic T lymphocytesNature, 341
P. Weiden, N. Flournoy, E. Thomas, R. Prentice, A. Fefer, C. Buckner, R. Storb (1979)
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.The New England journal of medicine, 300 19
K. Falk, O. Rötzschke, Stefan Stevanovié, G. Jung, H. Rammensee (1991)
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 351
Pamela Smith, A. Brunmark, M. Jackson, T. Potter (1997)
Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL)The Journal of Experimental Medicine, 185
M. Bellone, G. Iezzi, A. Manfredi, M. Protti, P. Dellabona, G. Casorati, C. Rugarli (1994)
In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen‐presenting cellsEuropean Journal of Immunology, 24
F. Carbone, Mark Moore, James Sheil, M. Bevan (1988)
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptidesThe Journal of Experimental Medicine, 167
Man Man, Salter Salter, Engelhard Engelhard (1992)
Role of endogenous peptide in human alloreactive cytotoxic T lymphocyte responsesInt. Immunol., 4
Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membraneassociated or secreted forms of g -galactosidase. Immunogenetics 1989
Rammensee Rammensee, Schild Schild, Theopold Theopold (1989)
Protein‐specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane‐associated or secreted forms of β‐galactosidaseImmunogenetics, 30
P. Panina-Bordignon, G. Corradin, E. Roosnek, A. Sette, A. Lanzavecchia (1991)
Recognition by class II alloreactive T cells of processed determinants from human serum proteinsScience, 252
H. Rammensee, M. Bevan (1984)
Evidence from in vitro studies that tolerance to self antigens is MHC-restrictedNature, 308
R. Brock, K. Wiesmüller, G. Jung, P. Walden (1996)
Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor.Proceedings of the National Academy of Sciences of the United States of America, 93 23
F. Aosai, Claes Öhlén, H. Ljunggren, P. Höglund, L. Franksson, H. Ploegh, A. Townsend, K. Kärre, H. Stauss (1991)
Different types of allospecific CTL clones identified by their ability to recognize peptide loading‐defective target cellsEuropean Journal of Immunology, 21
D. Crumpacker, J. Alexander, Peter Cresswell, V. Engelhard (1992)
Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.Journal of immunology, 148 10
L. Sherman, Suchismita Chattopadhyay (1993)
The molecular basis of allorecognition.Annual review of immunology, 11
Antigen presenting cells from nonresponder strain 2 guinea pigs are fully competent to present bovine insulin B chain to respond-Eur
I. Trowbridge, J. Lesley, R. Schulte (1982)
Murine cell surface transferrin receptor: Studies with an anti‐receptor monoclonal antibodyJournal of Cellular Physiology, 112
S. Jameson, M. Bevan (1992)
Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb‐restricted ovalbumin peptide and an assessment of the predictive power of MHC‐binding motifsEuropean Journal of Immunology, 22
A. Guimezanes, T. Schumacher, H. Ploegh, A. Schmitt-Verhulst (1992)
A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I productEuropean Journal of Immunology, 22
Yuri Sykulev, Anders Brunmark, T. Tsomides, Shigeki Kageyama, Michael Jackson, Per Peterson, Herman Eisen (1994)
High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.Proceedings of the National Academy of Sciences of the United States of America, 91 24
(1997)
Tissue specific cytotoxic T-cells produced by subtractive immunization in vitro
H. Kolb, A. Schattenberg, J. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, F. Rhee, J. Mittermueller, T. Witte, E. Holler, H. Ansari (1995)
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.Blood, 86 5
H. Rammensee, J. Lesley, I. Trowbridge, M. Bevan (1985)
Antibodies against the transferrin receptor block the induction of cytotoxic T lymphocytes. A new method for antigen‐specific negative selection in vitroEuropean Journal of Immunology, 15
O. Rötzschke, K. Falk, S. Faath, H. Rammensee (1991)
On the nature of peptides involved in T cell alloreactivityThe Journal of Experimental Medicine, 174
J. Connolly (1994)
The peptide p2Ca is immunodominant in allorecognition of Ld by beta chain variable region V beta 8+ but not V beta 8- strains.Proceedings of the National Academy of Sciences of the United States of America, 91 24
H. Kolb, J. Mittermuller, Ch. Clemm, E. Holler, G. Ledderose, G. Brehm, M. Heim, W. Wilmanns (1990)
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.Blood, 76 12
E. Groves, A. Singer (1983)
Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigensThe Journal of Experimental Medicine, 158
Evidence against a determinant selection model and in favour of a clonal deletion model of immune response gene function
A. Decloux, A. Woods, R. Cotter, M. Soloski, J. Forman (1997)
Dominance of a single peptide bound to the class I(B) molecule, Qa-1b.Journal of immunology, 158 5
S. Demotz, A. Sette, K. Sakaguchi, R. Buchner, E. Appella, H. Grey (1991)
Self peptide requirement for class II major histocompatibility complex allorecognition.Proceedings of the National Academy of Sciences of the United States of America, 88 19
Weiden Weiden, Sullivan Sullivan, Flourney Flourney, Storb Storb, Thomas Thomas (1981)
Antileukemic effect of chronic graft‐versus‐host diseaseN. Engl. J Med., 304
W. Heath, K. Kane, M. Mescher, L. Sherman (1991)
Alloreactive T cells discriminate among a diverse set of endogenous peptides.Proceedings of the National Academy of Sciences of the United States of America, 88
H. Schild, M. Norda, K. Deres, K. Falk, O. Rötzschke, K. Wiesmuller, G. Jung, H. Rammensee (1991)
Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptideThe Journal of Experimental Medicine, 174
Esperanza, Papadopoulos, Matthew, Carabasi, Lilian Reich, N. Collins, F. Boulad, Castro-Malaspina, Barrett, Childs, Alfred, N. Kernan, T. Small, James, Young, R. O'reilly (1995)
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.Blood, 86 4
N. Poindexter, B. Naziruddin, D. Mccourt, T. Mohanakumar (1995)
Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.Journal of immunology, 154 8
R. Henderson, A. Cox, K. Sakaguchi, E. Appella, J. Shabanowitz, D. Hunt, V. Engelhard (1993)
Direct identification of an endogenous peptide recognized by multiple HLA-A2.1-specific cytotoxic T cells.Proceedings of the National Academy of Sciences of the United States of America, 90 21
Kirsten Falk, K. Deres, rg Metzger, Günther Jung, H. Rammensee (1991)
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecastThe Journal of Experimental Medicine, 174
J. Connolly
The peptide p 2 Ca is immunodominant in allorecognition of Ld by . 8 chain variable region Vf 38 but not V 18-strains
C. Aldrich, A. Decloux, A. Woods, R. Cotter, M. Soloski, J. Forman (1994)
Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigenCell, 79
P. Weiden, K. Sullivan, N. Flournoy, R. Storb, E. Thomas (1981)
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.The New England journal of medicine, 304 25
M. Gavin, Beverley Dere, A. Grandea, K. Hogquist, M. Bevan (1994)
Major histocompatibility complex class I allele‐specific peptide libraries: Identification of peptides that mimic an H‐Y T cell epitopeEuropean Journal of Immunology, 24
Michael Bevan (1984)
High determinant density may explain the phenomenon of alloreactivity.Immunology today, 5 5
S. Alberti (1996)
A high affinity T cell receptor?Immunology and Cell Biology, 74
W. Heath, L. Sherman (1991)
Cell‐type‐specific recognition of allogeneic cells by alloreactive cytotoxic T cells: A consequence of peptide‐dependent allorecognitionEuropean Journal of Immunology, 21
P. Matzinger, M. Bevan (1977)
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens?Cellular immunology, 29 1
W. Wang, P. Gulden, R. Pierce, J. Shabanowitz, S. Man, D. Hunt, V. Engelhard (1997)
A naturally processed peptide presented by HLA-A*0201 is expressed at low abundance and recognized by an alloreactive CD8+ cytotoxic T cell with apparent high affinity.Journal of immunology, 158 12
Matzinger Matzinger, Zamoyska Zamoyska, Waldmann Waldmann (1984)
Self tolerance is H‐2‐restrictedNature, 308
BALB/c‐derived spleen cells were depleted of cytotoxic T lymphocytes (CTL) recognizing allogeneic (H2b) and TAP‐negative cells followed by stimulation with the same cells loaded with a synthetic library binding to H2‐Kb. The resulting CTL lines were found to differ widely in peptide specificity and to exhibit an avidity towards the library as that demonstrated for syngeneic CTL. These results demonstrate that positive selection in the context of a certain MHC molecule does not seem to be required for generating high‐avidity TCR that are restricted by the same molecule. However, positive selection increases the frequency of such CTL. By raising T cell lines from a repertoire which did not undergo negative selection by the restriction element in question, it becomes possible to produce effective self‐peptide/MHC as well as nonself‐peptide/MHC‐specific CTL as tools for adoptive tumor immunotherapy.
European Journal of Immunology – Wiley
Published: Aug 1, 1998
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.